Antares Pharma, Inc. (ATRS)

R&D Expense Growth

28.67%

Quarterly · Period ending:

ATRS logo

ATRS R&D Expense Growth

Latest reported28.67%
ATRS Quarterly R&D Growth (QoQ) (0.00% → 28.67%)
High-resolution chart · PNG

ATRS r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Antares Pharma, Inc. R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-23.548%
30.801%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.